Latham & Watkins, in partnership with LifeSci Advisors, is pleased to co-host a series of comprehensive panel discussions on topics that are of particular interest to European-based foreign private issuers and their advisors in the life sciences sector.
This session will focus strictly on the UK life sciences eco-system, and is intended to provide clarity around the legal, investment, and regulatory processes applicable to capital-raising activities in the United States. Topics will cover initial public offerings and alternative routes to going public, as well as what it takes to attract US investors and the benefits of listing in the US.
Michael Baldock, CFO, Abcam
Wesley Holmes, Life Sciences Corporate Partner, Latham & Watkins
Chris Maggos, Managing Director, Head of Europe, LifeSci Advisors
Nicholas Moore, Managing Director, Healthcare, Stifel
Jordan Saxe, Head of Healthcare, Listings & Capital Markets, Nasdaq
Please email email@example.com to register your interest in attending this event.